Cargando…
The IL-15 superagonist ALT-803 enhances anti-CD20 antibody-directed NK cell ADCC and in vivo clearance of B cell lymphomas
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288551/ http://dx.doi.org/10.1186/2051-1426-2-S3-P168 |
| _version_ | 1782351987420954624 |
|---|---|
| author | Rosario, Maximillian Liu, Bai Kong, Lin Schneider, Stephanie E Jeng, Emily K Rhode, Peter R Wong, Hing C Fehniger, Todd A |
| author_facet | Rosario, Maximillian Liu, Bai Kong, Lin Schneider, Stephanie E Jeng, Emily K Rhode, Peter R Wong, Hing C Fehniger, Todd A |
| author_sort | Rosario, Maximillian |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4288551 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42885512015-01-15 The IL-15 superagonist ALT-803 enhances anti-CD20 antibody-directed NK cell ADCC and in vivo clearance of B cell lymphomas Rosario, Maximillian Liu, Bai Kong, Lin Schneider, Stephanie E Jeng, Emily K Rhode, Peter R Wong, Hing C Fehniger, Todd A J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288551/ http://dx.doi.org/10.1186/2051-1426-2-S3-P168 Text en Copyright © 2014 Rosario et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Rosario, Maximillian Liu, Bai Kong, Lin Schneider, Stephanie E Jeng, Emily K Rhode, Peter R Wong, Hing C Fehniger, Todd A The IL-15 superagonist ALT-803 enhances anti-CD20 antibody-directed NK cell ADCC and in vivo clearance of B cell lymphomas |
| title | The IL-15 superagonist ALT-803 enhances anti-CD20 antibody-directed NK cell ADCC and in vivo clearance of B cell lymphomas |
| title_full | The IL-15 superagonist ALT-803 enhances anti-CD20 antibody-directed NK cell ADCC and in vivo clearance of B cell lymphomas |
| title_fullStr | The IL-15 superagonist ALT-803 enhances anti-CD20 antibody-directed NK cell ADCC and in vivo clearance of B cell lymphomas |
| title_full_unstemmed | The IL-15 superagonist ALT-803 enhances anti-CD20 antibody-directed NK cell ADCC and in vivo clearance of B cell lymphomas |
| title_short | The IL-15 superagonist ALT-803 enhances anti-CD20 antibody-directed NK cell ADCC and in vivo clearance of B cell lymphomas |
| title_sort | il-15 superagonist alt-803 enhances anti-cd20 antibody-directed nk cell adcc and in vivo clearance of b cell lymphomas |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288551/ http://dx.doi.org/10.1186/2051-1426-2-S3-P168 |
| work_keys_str_mv | AT rosariomaximillian theil15superagonistalt803enhancesanticd20antibodydirectednkcelladccandinvivoclearanceofbcelllymphomas AT liubai theil15superagonistalt803enhancesanticd20antibodydirectednkcelladccandinvivoclearanceofbcelllymphomas AT konglin theil15superagonistalt803enhancesanticd20antibodydirectednkcelladccandinvivoclearanceofbcelllymphomas AT schneiderstephaniee theil15superagonistalt803enhancesanticd20antibodydirectednkcelladccandinvivoclearanceofbcelllymphomas AT jengemilyk theil15superagonistalt803enhancesanticd20antibodydirectednkcelladccandinvivoclearanceofbcelllymphomas AT rhodepeterr theil15superagonistalt803enhancesanticd20antibodydirectednkcelladccandinvivoclearanceofbcelllymphomas AT wonghingc theil15superagonistalt803enhancesanticd20antibodydirectednkcelladccandinvivoclearanceofbcelllymphomas AT fehnigertodda theil15superagonistalt803enhancesanticd20antibodydirectednkcelladccandinvivoclearanceofbcelllymphomas AT rosariomaximillian il15superagonistalt803enhancesanticd20antibodydirectednkcelladccandinvivoclearanceofbcelllymphomas AT liubai il15superagonistalt803enhancesanticd20antibodydirectednkcelladccandinvivoclearanceofbcelllymphomas AT konglin il15superagonistalt803enhancesanticd20antibodydirectednkcelladccandinvivoclearanceofbcelllymphomas AT schneiderstephaniee il15superagonistalt803enhancesanticd20antibodydirectednkcelladccandinvivoclearanceofbcelllymphomas AT jengemilyk il15superagonistalt803enhancesanticd20antibodydirectednkcelladccandinvivoclearanceofbcelllymphomas AT rhodepeterr il15superagonistalt803enhancesanticd20antibodydirectednkcelladccandinvivoclearanceofbcelllymphomas AT wonghingc il15superagonistalt803enhancesanticd20antibodydirectednkcelladccandinvivoclearanceofbcelllymphomas AT fehnigertodda il15superagonistalt803enhancesanticd20antibodydirectednkcelladccandinvivoclearanceofbcelllymphomas |